Please login to the form below

Not currently logged in
Email:
Password:

Convergence and Selcia enter collaboration

Newly launched biotech, Convergence Pharmaceuticals, and contract research organisation, Selcia, have entered into a collaboration aiming to discover molecules to treat chronic pain
Convergence Pharmaceuticals, a UK-based pharmaceutical company recently launched out of GlaxoSmithKline (GSK), and Selcia, a contract research organisation, have entered into a drug discovery collaboration aiming to identify and develop compounds for the treatment of chronic pain. 

Under the terms of the agreement, Convergence Pharmaceuticals will apply its ion channel biology platform, medicinal chemistry know-how and preclinical development expertise to Selcia's medicinal chemistry and chemistry support services. Financial terms were not disclosed. 

Commenting on the announcement, Dr Ged Giblin, head of chemistry and preclinical development at Convergence Pharmaceuticals, said: "We believe the combination of Convergence's platform and Selcia's bespoke approach will provide an innovative model for this drug discovery partnership in finding solutions for a major unmet clinical need."

In the UK alone, four out of five initial visits to the general practitioner (GP) involve pain as the primary symptom, and prescription rates for analgesic medications are the second highest. By 2023 the chronic pain market in the seven major pharmaceutical markets is predicted to reach over $47bn. In the same seven pharmaceutical markets, 160 million people are estimated to suffer from osteoarthritis, 36 million people from chronic lower back pain and sciatica and over 10 million from neuropathic (or nerve) pain.

23rd November 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics